Clinical Trials Browser

Phase 2 × Solid Tumor × spartalizumab × Clear all

NCT04569916 2020-09-30

Radiotherapy Combined With Irinotecan and Apatinib Followed by PD-1 Antibody and Apatinib for Advanced Solid Tumors

Phase 2 Unknown

Other solid neoplasm

Solid Tumor